A flexural exanthem following postexposure prophylaxis

Clin Exp Dermatol. 2022 Jun;47(6):1204-1206. doi: 10.1111/ced.15131. Epub 2022 Mar 17.

Abstract

We report a case of symmetrical drug-related intertriginous and flexural exanthema following antiretroviral postexposure prophylactic medications, tenofovir and emtricitabine, commencement of which preceded the onset of the rash. Tenofovir and emtricitabine are both nucleoside reverse transcriptase inhibitor medications, commonly used to prevent development of AIDS.

Publication types

  • Case Reports

MeSH terms

  • Emtricitabine / adverse effects
  • Exanthema* / chemically induced
  • HIV Infections* / drug therapy
  • HIV Infections* / prevention & control
  • Humans
  • Tenofovir / adverse effects

Substances

  • Tenofovir
  • Emtricitabine